Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
NCT00261950
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
110
Enrollment
INDUSTRY
Sponsor class
Conditions
Secondary Hyperparathyroidism
Interventions
DRUG:
Sensipar (Cinacalcet HCl)
Sponsor
Amgen